Thomas Lendvay
Pediatric Urology · Seattle, WANPI 1417038779
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $956,592 of the $957,437 with a category attached, or 99.9%. Johnson & Johnson accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $956,592 and has fallen 100.0% since, to $41 in 2025.
Across 6 payments — averaging $159,573 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$957K
- Verathon Inc.$800
- Travere Therapeutics, Inc.$4
What the payments were for
- Consulting fees$8000%
- Speaking & faculty fees$956,592100%
- Food & beverage$410%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 4 | $956,633 |
| Verathon Inc. | 1 | $800 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric urology providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Other pediatric urology in Seattle
- Devon Snow-LisySeattle$2K
- Hailey SilveriiSeattle$1K
- Mark CainSeattle$1K
- Jose FernandezSeattle$284
- Jennifer AhnSeattle$265
- Paul MerguerianSeattle$148
- Lauren PoniatowskiSeattle$24
- Margarett ShnorhavorianSeattle$4
- Karmon JanssenTacoma$5K
- Jonathan KalisvaartSpokane$813
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.